Patents by Inventor Paul R. Solheim

Paul R. Solheim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147396
    Abstract: A medical device is configured to produce a cardiac motion signal by sampling a signal produced by an axis of a motion sensor, starting a blanking period, suspending the sampling of the signal during at least a portion of the blanking period, and restarting the sampling of the signal at the sampling frequency before the blanking period has expired. The medical device may detect a cardiac event from the cardiac motion signal and generate a pacing pulse in response to detecting the cardiac event in some examples.
    Type: Application
    Filed: November 12, 2019
    Publication date: May 14, 2020
    Inventors: Todd J. SHELDON, Vincent P. GANION, Greggory R. HERR, Michael L. HUDZIAK, Juliana E. PRONOVICI, Paul R. SOLHEIM
  • Publication number: 20200121931
    Abstract: An implantable medical device includes an activity sensor, a pulse generator, and a control module. The control module is configured to determine activity metrics from the activity signal and determine an activity metric value at a predetermined percentile of the activity metrics. The control module sets a lower pacing rate set point based on the activity metric value at the predetermined percentile.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventors: Todd J. SHELDON, Wade M. DEMMER, Karen J. KLECKNER, Douglas A. PETERSON, Paul R. SOLHEIM
  • Publication number: 20200094065
    Abstract: An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical stimulation therapy to a patient's heart via the electrodes coupled to the implantable medical device. The control circuit is configured to control the sensing circuit to set a starting value of the cardiac event sensing threshold and hold the starting value constant for a sense delay interval. The control circuit is further configured to detect an arrhythmia based on cardiac events sensed by the sensing circuit and control the therapy delivery circuit to deliver the electrical stimulation therapy in response to detecting the arrhythmia.
    Type: Application
    Filed: November 26, 2019
    Publication date: March 26, 2020
    Inventors: Jian CAO, Timothy A. EBELING, Saul E. GREENHUT, Michael W. HEINKS, Irving J. SANCHEZ, Paul R. SOLHEIM, Xusheng ZHANG, Gerald P. ARNE
  • Patent number: 10583306
    Abstract: An implantable cardioverter defibrillator (ICD) starts a timer set to a time interval in response to a cardiac electrical signal crossing a noise threshold amplitude and resets the timer to the time interval in response to each crossing of the noise threshold amplitude by the cardiac electrical signal that occurs prior to the time interval expiring. A control circuit of the ICD determines a parameter of the behavior of the timer and identifies a sensed cardiac event as an electromagnetic interference (EMI) event based on the parameter. The ICD may detect EMI in response to the EMI event and withhold a tachyarrhythmia detection or therapy in response to EMI detection.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: March 10, 2020
    Assignee: Medtronic, Inc.
    Inventors: Xusheng Zhang, Saul E. Greenhut, Michael W. Heinks, Paul R. Solheim
  • Publication number: 20200038665
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: October 14, 2019
    Publication date: February 6, 2020
    Inventors: Hyun J. YOON, Wade M. DEMMER, Matthew J. HOFFMAN, Robert A. BETZOLD, Jonathan D. EDMONSON, Michael L. ELLINGSON, Mark K. ERICKSON, Ben W. HERBERG, Juliana E. PRONOVICI, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM
  • Publication number: 20200030618
    Abstract: In some examples, controlling delivery of therapy includes using an implantable medical device comprising at least one electrode. Processing circuitry of a system comprising the device may receive, from an application running on a patient personal device, a patient request entered by the patient into the application. The processing circuitry may further determine, based on the patient request, a requested value of a therapy parameter, compare the requested value to information stored in a memory of the medical device system, the information indicating one or more allowable values of the therapy parameter, determine that the requested value is one of the allowable values based on the comparison of the requested value of the therapy parameter to the one or more allowable values, and control the implantable medical device to deliver cardiac pacing via the at least one electrode according to the requested value for a period of time.
    Type: Application
    Filed: July 27, 2018
    Publication date: January 30, 2020
    Inventors: Reece W. Holbrook, Nathan E. Johnson, Paul R. Solheim, Patrick D. Wells
  • Patent number: 10518094
    Abstract: An implantable medical device includes an activity sensor, a pulse generator, and a control module. The control module is configured to determine activity metrics from the activity signal and determine an activity metric value at a predetermined percentile of the activity metrics. The control module sets a lower pacing rate set point based on the activity metric value at the predetermined percentile.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: December 31, 2019
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Wade M. Demmer, Karen J. Kleckner, Douglas A. Peterson, Paul R. Solheim
  • Patent number: 10493291
    Abstract: An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical stimulation therapy to a patient's heart via the electrodes coupled to the implantable medical device. The control circuit is configured to control the sensing circuit to set a starting value of the cardiac event sensing threshold and hold the starting value constant for a sense delay interval. The control circuit is further configured to detect an arrhythmia based on cardiac events sensed by the sensing circuit and control the therapy delivery circuit to deliver the electrical stimulation therapy in response to detecting the arrhythmia.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: December 3, 2019
    Assignee: Medtronic, Inc.
    Inventors: Jian Cao, Timothy A. Ebeling, Saul E. Greenhut, Michael W. Heinks, Irving J. Sanchez, Paul R. Solheim, Xusheng Zhang, Gerald P. Arne
  • Patent number: 10441798
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: October 15, 2019
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Mark K. Erickson, Ben E. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Publication number: 20190262604
    Abstract: Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 29, 2019
    Inventors: Hyun J. YOON, Michael L. ELLINGSON, Wade M. DEMMER, Jonathan D. EDMONSON, Matthew J. HOFFMAN, Ben W. HERBERG, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM, Alison M. SEACORD
  • Publication number: 20190262620
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 29, 2019
    Inventors: Hyun J. YOON, Wade M. DEMMER, Matthew J. HOFFMAN, Robert A. BETZOLD, Jonathan D. EDMONSON, Michael L. ELLINGSON, Ben W. HERBERG, Juliana E. PRONOVICI, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM
  • Patent number: 10293167
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: May 21, 2019
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Patent number: 10286209
    Abstract: Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: May 14, 2019
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Michael L. Ellingson, Wade M. Demmer, Jonathan D. Edmonson, Matthew J. Hoffman, Ben W. Herberg, James D. Reinke, Todd J. Sheldon, Paul R. Solheim, Alison M. Seacord
  • Publication number: 20190117985
    Abstract: An implantable medical device system is configured to sense cardiac events in response to a cardiac electrical signal crossing a cardiac event sensing threshold. A control circuit is configured to determine a drop time interval based on a heart rate and control a sensing circuit to hold the cardiac event sensing threshold at a threshold value during the drop time interval.
    Type: Application
    Filed: October 23, 2017
    Publication date: April 25, 2019
    Inventors: Jian CAO, Gerald P. ARNE, Timothy A. EBELING, Yanina GRINBERG, Michael W. HEINKS, Paul R. SOLHEIM, Xusheng ZHANG
  • Patent number: 10252071
    Abstract: An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical stimulation therapy to a patient's heart via the electrodes coupled to the implantable medical device. The control circuit is configured to control the sensing circuit to set a starting value of the cardiac event sensing threshold and hold the starting value constant for a sense delay interval. The control circuit is further configured to detect an arrhythmia based on cardiac events sensed by the sensing circuit and control the therapy delivery circuit to deliver the electrical stimulation therapy in response to detecting the arrhythmia.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: April 9, 2019
    Assignee: Medtronic, Inc.
    Inventors: Jian Cao, Timothy A. Ebeling, Saul E. Greenhut, Michael W. Heinks, Irving J. Sanchez, Paul R. Solheim, Xusheng Zhang, Gerald P. Arne
  • Publication number: 20190083804
    Abstract: An implantable cardioverter defibrillator (ICD) receives a cardiac electrical signal by a sensing circuit while operating in a sensing without pacing mode and detects asystole based on the cardiac electrical signal. The ICD determines, in response to detecting the asystole, if asystole backup pacing is enabled, and automatically switches to a temporary pacing mode in response to the asystole backup pacing being enabled. Other examples of detecting asystole and providing a response to detecting asystole by the ICD are described herein.
    Type: Application
    Filed: November 19, 2018
    Publication date: March 21, 2019
    Inventors: Yanina GRINBERG, Robert T. SAWCHUK, Amy E. THOMPSON-NAUMAN, Douglas A. PETERSON, Paul R. SOLHEIM, Joel R. LAUER
  • Publication number: 20190054297
    Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 21, 2019
    Inventors: Xusheng ZHANG, Yanina GRINBERG, Paul R. SOLHEIM, Troy E. JACKSON, Timothy A. EBELING, Vladimir P. NIKOLSKI
  • Publication number: 20180339164
    Abstract: An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical stimulation therapy to a patient's heart via the electrodes coupled to the implantable medical device. The control circuit is configured to control the sensing circuit to set a starting value of the cardiac event sensing threshold and hold the starting value constant for a sense delay interval. The control circuit is further configured to detect an arrhythmia based on cardiac events sensed by the sensing circuit and control the therapy delivery circuit to deliver the electrical stimulation therapy in response to detecting the arrhythmia.
    Type: Application
    Filed: August 3, 2018
    Publication date: November 29, 2018
    Inventors: Jian CAO, Timothy A. EBELING, Saul E. GREENHUT, Michael W. HEINKS, Irving J. SANCHEZ, Paul R. SOLHEIM, Xusheng ZHANG, Gerald P. ARNE
  • Patent number: 10130824
    Abstract: An implantable cardioverter defibrillator (ICD) receives a cardiac electrical signal by a sensing circuit while operating in a sensing without pacing mode and detects asystole based on the cardiac electrical signal. The ICD determines, in response to detecting the asystole, if asystole backup pacing is enabled, and automatically switches to a temporary pacing mode in response to the asystole backup pacing being enabled. Other examples of detecting asystole and providing a response to detecting asystole by the ICD are described herein.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: November 20, 2018
    Assignee: Medtronic, Inc.
    Inventors: Yanina Grinberg, Robert T. Sawchuk, Amy E. Thompson-Nauman, Douglas A. Peterson, Paul R. Solheim, Joel R. Lauer
  • Patent number: 10096350
    Abstract: Memory array, system and method for storing data. The memory array has a flash memory array, a random access memory array coupled to the flash memory and configured to receive the data, a memory management module and a data bus. The memory management module is coupled to the random access memory array and to the flash memory array, the memory management module being configured to transfer at least a portion of the data stored in the random access memory array to the flash memory array. The data bus is coupled to the flash memory array and configured to output at least a portion of the data originally stored in the random access memory array from the flash memory array.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: October 9, 2018
    Assignee: Medtronic, Inc.
    Inventors: Kevin K. Walsh, Charles R. Gordon, Paul R. Solheim, Jerry D. Reiland, Robert D. Musto, Duane R. Bigelow